Literature DB >> 31480046

Crizotinib-Associated Renal Cysts in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients: A Single-Center Experience.

Panuch Eiamprapaporn1, Naphapatt Mungwatthana1, Prin Twinprai2, Aumkhae Sookprasert1, Jarin Chindaprasirt1, Anucha Ahooja2, Sirinthip Watthanaudomrot3, Wichien Sirithanaphol4.   

Abstract

Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3 cases of crizotinib-associated renal cysts in patients admitted to our institution, with different kinds of presentation. A monitor for complex renal cysts is warranted in patients receiving crizotinib.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Adverse effects; Anaplastic lymphoma kinase; Embolization; Lung cancer; Non-small cell lung cancer

Year:  2019        PMID： 31480046     DOI： 10.1159/000502664

Source DB:  PubMed          Journal:  Urol Int        ISSN： 0042-1138            Impact factor:   2.089


  1 in total

1.  Renal Abscess Caused by Crizotinib: A Rare Case Report.

Authors:  Zhaojun Wan; Kai Wang; Xiangfu Yin; Xiangting Guo; Guoli Cheng; Jihong Pan
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.